In particular, alterations in TIMP-1 and MMP-9 levels have been observed in subjects with lung cancer compared to controls, associated with a poor prognosis, indicating a possible role of TIMP-1 and MMP-9 as a prognostic marker [143]. This evidence concerns the gene TIMP1 and lung carcinoma.